Creatinine, a byproduct of muscle function, may be more sensitive in tracking SMA progression and response to treatment than ...
Patients with spinal muscular atrophy (SMA) type 2 showed improved motor ability when treated with intrathecal onasemnogene ...
Men with SMA are likely to have fertility issues, and patients with more severe motor impairments have lower sperm counts, ...
Travel + Leisure on MSN7d
I've Traveled to 44 Countries and All 7 Continents in a Wheelchair — Here's What It's LikeAccessible travel blog founder Cory Lee is committed to helping other wheelchair users travel the world freely.
Positive results from its Phase III STEER study mean Novartis could boost sales of its OAV101 IT drug for spinal muscular ...
Advocates rallied outside the State House on Tuesday for special education funding.The group urged lawmakers to allocate more ...
Back to Healio Topline results from a phase 3 clinical trial showed an investigational gene therapy for young people with spinal muscular atrophy type 2 increased mobility and slowed disease ...
Crystal Rondeau’s muscle wasting disease has left her with only one finger to press an alarm button or send a text. The ...
Scholar Rock aims for a 2025 launch of apitegromab in SMA, expecting $2 billion in global revenue and significant growth from upcoming trials and favorable data.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback